This study exists to see whether this type of care is workable and worth testing more broadly. Researchers are trying to understand whether this type of care can give earlier or clearer feedback during care.

In United States

Bipolarity, DepressionDrugFrom 18 Years to 64 Years

Countries: United States
Sponsor: Cambridge Health Alliance
Condition: Bipolarity, Depression

View study

CompletedNCT00374348

Aripiprazole in the Treatment of people with Schizophrenia and Symptoms of OCD (OCD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

OCD, SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Jamaica Hospital Medical Center
Condition: OCD, Schizophrenia

View study

TerminatedNCT04203056

Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

Remote / online

Schizophrenia, DepressionDrugFrom 18 Years to 45 Years

Countries: United States
Sponsor: University of California, Los Angeles
Condition: Schizophrenia, Depression

View study

CompletedNCT01959035

Aripiprazole Once-monthly in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: H. Lundbeck A/S
Condition: Schizophrenia

View study

CompletedNCT01795547

Aripiprazole Once-monthly Versus Paliperidone Palmitate in adults with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: H. Lundbeck A/S
Condition: Schizophrenia

View study

CompletedNCT00102518

Aripiprazole Safety and Tolerability Study

This study is completed in the United States. It focuses on Schizophrenia.

In United States

Schizophrenia, BipolarityDrugFrom 10 Years to 17 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Schizophrenia, Bipolarity

View study

CompletedNCT00101569

Aripiprazole Oral Acceptability study

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugOver 18 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Schizophrenia

View study

CompletedNCT00276874

Aripiprazole to Reduce Cocaine Relapse

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 50 Years

Countries: United States
Sponsor: Craig Rush
Condition: Addiction

View study

CompletedNCT00198198

Aripiprazole Treatment of Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Bipolarity, DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Indiana University
Condition: Bipolarity, Depression

View study

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.